Optimisez l'adoption et les résultats des nouveaux traitements grâce à des programmes de soutien proposés aux patients.
Patients-jour télésurveillés.
des patients évaluent le service comme étant bon ou très bon
observance du traitement par Doccla RPM chez les patients.
Interactive platforms that increase patient engagement through intuitive app and devices, proven to boost treatment adherence
24/7 health metrics monitoring with real-time feedback and alerts, facilitating early intervention and continuous patient care
Flexible and scalable solutions tailored to meet specific therapeutic needs and patient populations, suitable for global deployment
Inscription au programme de soutien aux patients. Le patient reçoit des appareils adaptés à sa télésurveillance.
Le patient est intégré et formé à distance. Il utilise des appareils et une application pour transmettre des données cliniques.
Les professionnels de santé surveillent et traitent les données des patients à distance via le tableau de bord Web Doccla en temps quasi réel.
Les professionnels de santé assurent le suivi des patients via la messagerie et les appels vidéo dans l'application destinée aux patients.
Le patient est déchargé du DMN.
Les équipements sont récupérés et recyclés.
“This is a fantastic example of healthcare collaboration made possible by the strong relationships we have with our acute and primary care colleagues across the region, combined with the medical technological expertise provided by Doccla”
Medical Director
Hertfordshire Community NHS Trust
Browse through a comprehensive collection of research, best practices, and clinical guidelines tailored to virtual healthcare.
Global Head of Pharma Partnerships
Dr. Samuel Ewing has over a decade's experience in developing cutting-edge sensors and software ecosystems for remote patient monitoring across the disease spectrum. He spent many years leading technology selection and solution design for Roche's digital biomarker program and continues to drive the transformation of healthcare and clinical research with advanced technologies.
Life Science Director
Dr. Eduardo Arteaga Bracho has over 15 years of experience researching and developing solutions in the pharmaceutical and healthcare industries, as well as academia. He has designed and implemented patient-centric digital health technologies for numerous clinical trials and healthcare providers while at Roche and Biogen, collaborating closely with the medical and scientific communities.